Status

ShigETEC is due to enter clinical testing in 2020.

Headquarters

​

Eveliqure Biotechnologies GmbH

​

Campus Vienna Biocenter


Karl-Farkas-Gasse 22

A-1030 Vienna

Austria

  • White Facebook Icon
  • White LinkedIn Icon

© 2019 Eveliqure Biotechnologies GmbH